Neil Cashman
Founder bei PROMIS NEUROSCIENCES, INC.
Vermögen: 219 499 $ am 31.03.2024
Profil
Neil R.
Cashman is the founder of Caprion Proteomics, Inc. (founded in 2000) and ProMIS Neurosciences, Inc. (founded in 2004).
He is currently the Director-UBC ALS Centre & Professor at the University of British Columbia (since 2005), Director-ALS Clinic at Vancouver General Hospital (since 2005), Director at ALS Society of British Columbia, and Director at Alberta Innovates BioSolutions.
In the past, he was the Director-Neuromuscular Clinic at Sunnybrook & Womens Foundation and a Professor at the University of Toronto (1998-2005).
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 26.10.2023 | 114 921 ( 0,61% ) | 219 499 $ | 31.03.2024 |
Aktive Positionen von Neil Cashman
| Unternehmen | Position | Beginn |
|---|---|---|
| PROMIS NEUROSCIENCES, INC. | Founder | 23.01.2004 |
| University of British Columbia | Corporate Officer/Principal | 01.07.2005 |
| Vancouver General Hospital | Corporate Officer/Principal | 01.07.2005 |
Alberta Innovates BioSolutions
 Alberta Innovates BioSolutions BiotechnologyHealth Technology Alberta Innovates BioSolutions develops bioindustrial technologies and natural products. It delivers on the potential of agriculture and forestry in areas such as: value chain sustainability, advancing the biorefinery, quality food for health, industry challenges and emerging opportunities, and prion and prion-like protein misfolding diseases. The firm aims to be a global gateway and resource for bio-based research, talent, investment and solutions. The company was founded on January 1, 2010 and is headquartered in Edmonton, Canada. | Director/Board Member | - |
ALS Society of British Columbia
 ALS Society of British Columbia Miscellaneous Commercial ServicesCommercial Services ALS Society of British Columbia provides direct support to ALS patients, along with their families and caregivers. The firm's services include equipment loan program, patient transportation support, support groups, care connections program, and mobile clinics. The company is headquartered in Richmond, Canada. | Director/Board Member | - |
Ehemalige bekannte Positionen von Neil Cashman
| Unternehmen | Position | Ende |
|---|---|---|
| University of Toronto | Corporate Officer/Principal | 01.01.2005 |
Caprion Proteomics, Inc.
 Caprion Proteomics, Inc. Medical SpecialtiesHealth Technology Caprion Proteomics, Inc. provides proteomics and immune monitoring services to the pharmaceutical and biotechnology industry. It specializes in proteomics, biomarkers, discovery, validation, services, immune monitoring, flow cytometry and elispot areas. The company was founded by Neil Cashman and Martin LeBlanc in 2000 and is headquartered in Montreal, Canada. | Founder | - |
| Sunnybrook & Womens Foundation | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| PROMIS NEUROSCIENCES, INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
| Sunnybrook & Womens Foundation | |
| Vancouver General Hospital | |
ALS Society of British Columbia
ALS Society of British Columbia Miscellaneous Commercial ServicesCommercial Services ALS Society of British Columbia provides direct support to ALS patients, along with their families and caregivers. The firm's services include equipment loan program, patient transportation support, support groups, care connections program, and mobile clinics. The company is headquartered in Richmond, Canada. | Commercial Services |
Alberta Innovates BioSolutions
Alberta Innovates BioSolutions BiotechnologyHealth Technology Alberta Innovates BioSolutions develops bioindustrial technologies and natural products. It delivers on the potential of agriculture and forestry in areas such as: value chain sustainability, advancing the biorefinery, quality food for health, industry challenges and emerging opportunities, and prion and prion-like protein misfolding diseases. The firm aims to be a global gateway and resource for bio-based research, talent, investment and solutions. The company was founded on January 1, 2010 and is headquartered in Edmonton, Canada. | Health Technology |
Caprion Proteomics, Inc.
Caprion Proteomics, Inc. Medical SpecialtiesHealth Technology Caprion Proteomics, Inc. provides proteomics and immune monitoring services to the pharmaceutical and biotechnology industry. It specializes in proteomics, biomarkers, discovery, validation, services, immune monitoring, flow cytometry and elispot areas. The company was founded by Neil Cashman and Martin LeBlanc in 2000 and is headquartered in Montreal, Canada. | Health Technology |
